The basic science behind asthma biologics

S. Wenzel (Pittsburgh, United States of America)

Source: International Congress 2018 – New biologics for asthma: which patients, which agents, which results, at what cost?
Session: New biologics for asthma: which patients, which agents, which results, at what cost?
Session type: Lunchtime session
Number: 3168
Disease area: Airway diseases

WebcastSlide presentation

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Wenzel (Pittsburgh, United States of America). The basic science behind asthma biologics. International Congress 2018 – New biologics for asthma: which patients, which agents, which results, at what cost?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Are we really transforming asthma and COPD management with biologics?
Source: International Congress 2018 – State of the art session: Airways disease
Year: 2018


Biologic therapies in paediatric severe asthma
Source: ERS webinar 2020: Biologic therapies in paediatric severe asthma
Year: 2020


Is there a need for pharmacoepidemiology in asthma and COPD?
Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials
Year: 2004

New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012


Consultation on basic asthma research strategy
Source: Eur Respir J 2002; 20: 795-796
Year: 2002


COVID-19 and COPD: a narrative review of the basic science and clinical outcomes
Source: Eur Respir Rev, 29 (158) 200199; 10.1183/16000617.0199-2020
Year: 2020



What is new in paediatric asthma?
Source: Annual Congress 2006 - Paediatric year in review
Year: 2006


New perspectives of basic aspirin-induced asthma therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 104s
Year: 2003

The future of personalised medicine in COPD
Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease
Year: 2016


Systems biology and big data in asthma and allergy: recent discoveries and emerging challenges
Source: Eur Respir J, 55 (1) 1900844; 10.1183/13993003.00844-2019
Year: 2020



Challenges in COPD exacerbations and future research and unknowns
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013

Predictive and personalised medicine for asthma using genomics
Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Year: 2012


Will artificial intelligence really transform clinical practice? Applications in asthma and COPD
Source: Virtual Congress 2021 – Airway diseases
Year: 2021


In the era of personalized medicine, what are the current unmet needs in asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019